Pressure Biosciences INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Pressure BioSciences has experienced significant delays in filing its financial reports due to severe weather events in Houston, Texas, impacting its accounting firm and resulting in a temporary move to the OTC Expert Market.
OTC.Pink
Two members of Pressure BioSciences' Board of Directors, Kevin A. Pollack and Vito J. Mangiardi, have resigned effective immediately, with the board choosing not to fill the vacancies at this time.
OTC.Pink
Pressure BioSciences, Inc. held a special stockholder meeting on April 18, 2024, where they elected a director, ratified the appointment of an independent auditor, and approved a new equity incentive plan.
OTC.Pink
Pressure BioSciences has acquired Uncle Buds in an all-stock transaction, aiming to integrate their technologies and achieve over $10 million in revenue in 2024.